Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Triple Negative Breast Neoplasms × Bortezomib × Clear all

Sponsor

Conditions

Multiple Myeloma 131 Lymphoma, Mantle-Cell 27 Neoplasms, Plasma Cell 19 Lymphoma, Follicular 19 Lymphoma 19 Lymphoma, Non-Hodgkin 18 Recurrence 15 Leukemia, Myeloid, Acute 12 Waldenstrom Macroglobulinemia 11 Precursor Cell Lymphoblastic Leukemia-Lymphoma 11 Lymphoma, Large B-Cell, Diffuse 10 Immunoglobulin Light-chain Amyloidosis 10 Lymphoma, B-Cell, Marginal Zone 8 Leukemia, Lymphocytic, Chronic, B-Cell 8 Neoplasms 7 Leukemia 6 Carcinoma, Non-Small-Cell Lung 6 Myelodysplastic Syndromes 5 Hematologic Neoplasms 5 Lymphoma, Large-Cell, Immunoblastic 4 Lymphoma, B-Cell 4 Hematologic Diseases 4 Congenital Abnormalities 4 Brain Neoplasms 4 Amyloidosis 4 Paraproteinemias 3 Leukemia, Myelomonocytic, Acute 3 Leukemia, Monocytic, Acute 3 Leukemia, Erythroblastic, Acute 3 Leukemia, B-Cell 3

Interventions

Paclitaxel 33 pembrolizumab 30 Carboplatin 28 Cyclophosphamide 18 Albumin-Bound Paclitaxel 18 Taxes 15 130-nm albumin-bound paclitaxel 15 Doxorubicin 14 atezolizumab 13 Capecitabine 13 Cisplatin 11 Nivolumab 9 Docetaxel 8 olaparib 7 Gemcitabine 6 talazoparib 5 durvalumab 5 Everolimus 5 Biopsy 5 Bevacizumab 5 spartalizumab 4 pegfilgrastim 4 liposomal doxorubicin 4 eribulin 4 Magnetic Resonance Spectroscopy 4 Immunoglobulin G 4 sacituzumab govitecan 3 entinostat 3 bintrafusp alfa protein, human 3 Trastuzumab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡